Effects of Innovative Aerobic Exercise Training in Cystic Fibrosis

Last updated: October 7, 2024
Sponsor: University of Kansas Medical Center
Overall Status: Completed

Phase

N/A

Condition

Scar Tissue

Cystic Fibrosis

Lung Disease

Treatment

exercise

Clinical Study ID

NCT04543929
STUDY00143513
  • Ages > 18
  • All Genders

Study Summary

The main objective of this study is to compare the effectiveness of two different exercise interventions in a patient-centered, home-based exercise program for improving cardiorespiratory-fitness in people with cystic fibrosis (CF). We hypothesize cystic fibrosis patients participating in a high intensity interval training (HIIT) group will experience greater improvements in cardiorespiratory-fitness than those in a moderate continuous training (MCT) group. Further, we plan to investigate the efficacy of the comparators on patient-centered outcomes.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • diagnosed with Cystic Fibrosis

  • Prescribed and taking for 28 days ivacaftor-tezacaftor-elexacaftor (Trikafta)

  • 18 years and older

Exclusion

Exclusion Criteria:

  • 17 years of age or less

  • not eligible for ivacaftor-tezacaftor-elexacaftor (Trikafta)

  • inability to exercise

  • pregnancy

  • status post lung transplantation

  • already participating in more than 150 minutes of aerobic exercise per week

Study Design

Total Participants: 9
Treatment Group(s): 1
Primary Treatment: exercise
Phase:
Study Start date:
February 11, 2020
Estimated Completion Date:
June 23, 2020

Study Description

This study is a randomized control trial that compares MCT to HIIT using a patient-centered and home-based delivery model with CF Care Centers in the United States. Participants will be randomly allocated to either an MCT or HIIT arm. Both the MCT and HIIT interventions are accepted forms of prescribed exercise in clinical practice. The interventions will be delivered with a telehealth platform using internet (HIPAA-Compliant video), phone, and email/text support. All study sites will receive initial and on-going training and program facilitation to assure consistency of delivering the intervention. All participants across both arms visit their respective CF clinics on a regular basis for routine CF care. Thus, our research team will be able to coordinate all testing/assessment visits, including long-term (18-month timepoint), with participants throughout the study. The primary and secondary outcomes include important patient-centered outcomes as selected by our study's CF Patient and Stakeholder Advisory Board.

Connect with a study center

  • University of Kansas Medical Center

    Kansas City, Kansas 66160
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.